| (AUD) | Jun 2025 | Y/Y change |
|---|---|---|
| Revenue | 26.17M | 14.51% |
| Operating expense | — | — |
| Net income | -50.30M | 33.34% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, PYC.AX returned +61.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +26.9% |
| 1 year | +61.5% |
| 5 years | +41.7% |
| 10 years | +1258.9% |
| All-time high | $5.76 (May 2006) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in PYC.AX would be worth today ›No. PYC Therapeutics Limited has not paid a dividend in the past 12 months.
PYC Therapeutics Limited is part of the Healthcare sector.
PYC Therapeutics Limited has a market cap of 2.07B AUD, based on the latest quote.
